Inhibition of Dopamine Receptor in Neonate Hippocampus:

Immunolocalization of Post Synaptic Density Protein-95 and Dopamine

Receptor 

in vivo by Laoye, Babafemi J et al.
Inhibition of Dopamine Receptor in Neonate Hippocampus:
Immunolocalization of Post Synaptic Density Protein-95 and Dopamine
Receptor in vivo
Babafemi J Laoye1*, Oluwamolakun O Bankole1, Esther A Ekundayo1 and Azeez O Ishola2
1Department of Biological Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti, Nigeria
2Department of Anatomy, Neural Systems Unit, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria
*Corresponding author: Babafemi J Laoye, Department of Biological Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti, Nigeria, Tel:
(+234)8136916125; E-mail: babafemif@abuad.edu.ng
Received date: May 05, 2018; Accepted date: May 25, 2018; Published date: June 01, 2018
Copyright: © 2018 Laoye BJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
The effect of haloperidol on neonatal dopaminergic neurotransmission in the hippocampus of postnatal day 20
rats (P.20) was investigated in this study. Haloperidol blocked dopamine receptors (D2R) and inhibited D2R on the
membrane of neonate neurons. For this study the 0.5 ml (20 mg/kg) of haloperidol was administered to pregnant
female animals intraperitoneally a week before delivery. At day P.20, 5 control animals and 5 haloperidol treated
animals were taken to the behavioral studies room for the Y maze and Novel object recognition test, which was done
7 am in the morning before mating. Electrophysiology was done with 2 control pups and 2 treated pups. Electrodes
were implanted in the brain at the hippocampal region 2 mm beneath the bregma, 2 mm lateral to the midline.
Anterior Posterior (AP=0), Medial Lateral (ML=2 mm). Also immunolocalization and immunofluorescence of post
synaptic density protein (PSD-95), hippocampal morphology and hippocampal neurons have been done
respectively. Results from this study showed a decline in memory index for the Y maze as a result of the effect of
D2R blockade thereby inhibiting neurotransmission in newborns. Electrophysiology result in this study showed an
increase in the root mean square (RMS) of control pups. The increase in RMS is equivalent to increase in wave
burst pattern caused by neuronal excitation. Immunochemistry result showed an increase in the number of PSD-95
in the hippocampus of an increase in tyrosine hydroxylase in the hippocampus of the treated neonatal rats when
compared to the control neonatal rats Immunofluorescence showed decline in the number of neurons in the
haloperidol treated rats and it also caused hippocampal damage in terms of morphology. Furthermore, results from
electrophysiology showed a statistical significant difference with P value 0.04229 (P<0.05) using the student t-test.
These findings suggest that D2R inhibition may cause decline in memory function, impair learning in newborns and
disrupt neonatal dopaminergic neurotransmission.
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Introduction
Dopamine Receptor (D2R) is a transmembrane receptor that is
responsible for the uptake of dopamine which is a neurotransmitter
secreted from the subtantia nigra in the mid brain for the purpose of
cognition, coordination and memory function via neuron to neuron
network [1]. Recent studies have shown that inhibition of D2R
receptors in neonates causes neurological disorders and it is clearly
visible in Parkinson’s characterized by bradykinesia, tremor gait
disorders etc. [2]. Also vesicular transport of D2R has been suspected
to be involved in the cause of progression of D2R related neurological
disorders such as Parkinson’s disease, schizophrenia and bipolar
disorder [3]. Dopamine is a neurotransmitter that is secreted at the
substatnsia nigra of the brain, which is responsible for movement,
coordination and cognition [4]. It is an organic chemical of the
catecholamine and phenethylamine families that plays several
important roles in the brain and body. Its name is derived from its
chemical structure: it is an amine synthesized by removing a carboxyl
group from a molecule of its precursor chemical Levodopa (L-DOPA),
which is synthesized in the brain and kidneys. It is also synthesized in
plants and most multicellular animals [5]. In the brain, dopamine
functions as a neurotransmitter a chemical released by neurons (nerve
cells) to send signals to other nerve cells. The brain includes several
distinct dopamine pathways, one of which plays a major role in
reward-motivated behavior. Most 2 types of reward increase the level
of dopamine in the brain, and most addictive drugs increase dopamine
neuronal activity. Other brain dopamine pathways are involved in
motor control and in controlling the release of various hormones.
These pathways and cell groups form a dopamine system which is
neuromodulatory [4]. Outside the central nervous system, it functions
in several parts of the peripheral nervous system as a local chemical
messenger. In blood vessels, it inhibits norepinephrine release and acts
as a vasodilator (at normal concentrations); in the kidneys, it increases
sodium excretion and urine output; in the pancreas, it reduces insulin
production; in the digestive system, it reduces gastrointestinal motility
and protects intestinal mucosa; and in the immune system, it reduces
the activity of lymphocytes. With the exception of the blood vessels,
dopamine in each of these peripheral systems is synthesized locally and
exerts its effects near the cells that release it [3].
Several important diseases of the nervous system are associated with
dysfunctions of the dopamine system, and some of the key
medications used to treat them work by altering the effects of
dopamine [4]. Parkinson's disease, a degenerative condition causing
tremor and motor impairment, is caused by a loss of dopamine-
secreting neurons in an area of the midbrain called the substantia nigra
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[6]. Studies have shown that antipsychotics such as Haloperidol which
causes dopamine receptor blockade may lead to Parkinsonism and
progressively lead to Schizophrenia [7]. Levodopa is the most widely
used treatment for the condition [5]. There is evidence that
schizophrenia involves altered levels of dopamine activity, and most
antipsychotic drugs used to treat this are dopamine antagonists which
reduce dopamine activity. Similar dopamine antagonist drugs are also
some of the most effective anti-nausea agents [5]. Restless legs
syndrome and Attention Deficit Hyperactivity Disorder (ADHD) are
associated with decreased dopamine activity [2]. Dopaminergic
stimulants can be addictive in high doses, but some are used at lower
doses to treat Attention Deficit Hyperactivity Disorder (ADHD).
Dopamine itself is available as a manufactured medication for
intravenous injection: although it cannot reach the brain from the
bloodstream, its peripheral effects make it useful in the treatment of
heart failure or shock, especially in newborn babies [2].
The aim of this study seeks to observe and examine D2R vesicle
trafficking and docking on the membrane of neurons and PSD-95
scaffolding proteins in the developing mouse brain of P.20 after
inhibiting D2R with Haloperidol and also to test for the effect of
Haloperidol on memory function in neonates. Experimental
Hypothesis: at the end of this study, we hypothesize that there would
be a decline in memory function in the Wistar rats treated with
haloperidol compared to the control group as a result of the blockage
of D2R receptors brought about by haloperidol which is a D2R blocker.
The specific objectives of this study are as follows: to compare the
burst pattern of the neurons of P.20 neonates via electrophysiology and
to determine the memory index of control and treated neonates via
behavioural studies.
Materials and Methods
Sixteen (16) F1 Albino Wistar rats (12 females, 4 males) were
purchased from the animal holding facility of Afe Babalola University
Ado-Ekiti, Ekiti State, Nigeria. Haloperidol was purchased from Reich
Pharmacy, Nigeria. Antibodies were purchased from ABCAM, USA.
Animal preparation
The animals were housed in the animal holding facility of Afe
Babalola University, Nigeria. The animals were allowed to acclimatize
to the new environment for 1 week. The animals were kept under
alternating light and darkness with rat chow and water being given to
the animals daily.
The albino Wistar rats were kept in separate cages, 4 animals per
cage in 4 cages, having 3 females, one male in each cage. The animals
were being placed in such manner for the purpose of mating.
All protocols were in accordance with the IACUC animal use
guidelines and were approved by the Animal Use Ethical Committee of
the Afe Babalola University, Nigeria.
Mating
Mating was done at the second week after acclimatization, 3 female
albino Wistar rats and 1 male albino Wistar rat were placed in four
different cages.
Vaginal smear
Vaginal smear was performed every morning for the female rats
using the method of Marcondes et al. [8]. Pasteur pipette containing
normal saline was dipped into the vagina of the female albino Wistar
rat. The pipette was then used to suck up vaginal fluid. Two drops of
the fluid which has the vagina fluid and normal saline was then placed
on a glass slide and smeared. The smear was then observed underneath
the microscope, using 10X objective. The essence of this was to observe
the oestrus stage of the reproductive cycle of the albino rats. Any
female animals which were observed to have reached the oestrus stage
were separated to be alone with a male for constant mating. When the
female animals were suspected to be pregnant, they were weighed and
separated into different cages.
Haloperidol administration
The female animals were weighed and all the suspected pregnant
animals (Treatment Group) were injected intraperitoneally with 0.5 ml
(20 mg/kg haloperidol for 7 days. Treatment was done every morning
before the animals were fed with the rat chow.
Behavioral tests
Behavioral studies were done for the pups at P.20 after delivery. The
animals were taken through the Novel Object Recognition test (NOR)
and the Y maze test. The test was done for both control groups and
treatment groups.
Y Maze
The Y Maze Test was done very early in the morning for both
control and treatment groups pups at 7:30 am. 5 control and treatment
pups (P.20). The test was done to assay for the spatial working memory
index of the pups using the method of Adeniyi et al. [9] and each
control animal was placed in the Y maze and was allowed to navigate
and explore the 3 arms of the Maze for 3 minutes Observation of the
exploratory movement was done using a camera connected to a laptop
computer. The method used in this research is the method of Adeniyi
et al. [9] and Onaolapo et al. [10].
After this the memory index was then calculated.
Memory index=Number of right decisions ÷ Total arm entries-2 ×
100 [9].
There is a -2 because the total number of arm entries of the Y maze
is 3, and the animal is expected to enter only one arm at once. This
method is used by scientists all over the world for behavioral studies.
NOR test
The Novel object recognition test was done to assay for memory
function. The test was done for both control and treatment groups. 5
animals each (control and treatment). For the first trial 2 identical
objects were placed in a box and the animal was introduced into the
box to familiarize itself with the objects for 5 minutes. After this, the
second trial was done by replacing an identical object with an un-
identical object. The test was done for both control and treatment
group for 5 minutes and then the memory index was calculated.
Memory index=Time spent on new object ÷Time spent on both new
and old objects × 100 [9].
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Electrophysiology
Electrophysiology was performed with the use of fine electrodes and
copper wire, which were inserted to the brain of 4 pups (2 control and
2 treated), 2 mm beneath the bregma, 2 mm lateral to the midline.
Anterior Posterior (AP=0), Medial Lateral (ML=2 mm). The animals
were anaesthetized with ketamine. A small area on the scalp of the
animals was shaved to expose the bregma and region above the orbit.
A stereotaxic frame was used to hold the head of the animals in
position to determine the location hippocampus 2 mm to the bregma.
Hydrogen peroxide solution was used to clean the periosteum and
blood markings on the scalp and a drill was made through the cranium
using the coordinates. Then electrode was inserted on the 2 mm mark.
The rubber base of the electrode was then sealed with the use of
orthodontic resin and allowed to dry after which the spiker box was
switched on to take electrophysiology readings on the computer.
Electrophysiology readings were taken after putting the animal to
sleep with the use of 0.3 ml ketamine. The immobile awake animal was
then placed on a stereotaxic frame and electrodes connected to a spiker
box were used to take brain readings from the Hippocampus using
Audacity software and further analyzed in sigview software to get the
root mean square and epoch readings in form of a wave curve [11].
Immunohistochemistry (IHC)
Two pups of both control and treatment groups were used for
immunohistochemistry, the immobile awake animals were perfused
with normal saline after anesthetizing the animal with 0.3 ml of
ketamine and then with formal saline. The purpose of this was to
replace the blood with normal and formal saline to fix the brain tissue
and clear the blood on the brain, to make it neat and beautiful for IHC.
IHC was done with the use of anti PSD-95 and D2R anti body to label
PSD-95. Immunofluorescence was done to map out the hippocampal
neurons and the hippocampus with the use of vesicular GABA
transporter (VGAT) and 4, 6-Diamidino-2-phenylindole (DAPI)
respectively [12].
Cell count
Cell count of D2R receptors was performed using the image J
software model IJ 1.46r. The number of D2R receptors in the control
tissue was compared to that of the treated tissue [9].
Results
Y maze test
Spatial working memory was determined using Y-maze test. The
percentage alternation which is the function of memory index in the Y-
maze was determined to measure the spatial memory of the neonate
animals after a 7-day treatment with haloperidol during last week of
gestation. No significant statistical difference (P>0.05) was observed in
the spatial memory (Memory Index) when the treatment groups were
compared with the control although there was decrease in memory
index of the treatment group when compared with the control.
NOR test
Novel object recognition test was done to measure non-spatial
working memory of neonates (P.20) of animals with treatment of
haloperidol and normal saline during last week of gestation for 7 days.
Neonates of haloperidol treated mothers showed decline in the
memory index compared to control. There was no statistical significant
difference between the groups (P>0.05) using t-test even though the
memory index of the treatment group was lower (Figure 1).
Figure 1: Motor-Cognitive function determined in Y-Maze test and
NOR. (a) The total number of arm entries in the Y-Maze was
determined to measure exploratory motor function associated with
spatial memory after acute treatment duration. No significant
change (P>0.05) was observed in exploratory motor function when
the treatment groups were compared with the control. There was
decrease in memory index of the treatment group when compared
with the control which is shown on the graph. (b) For the Novel
Object Recognition Test was used to determine non spatial working
memory index of the neonates and results from the graph above
showed a decline in memory index in neonates of haloperidol
treated mothers but no statistical difference (P>0.05) was observed.
Discussion
Taken together, the outcome of this study confirms the role of
dopaminergic receptor (D2R blockade and decline of Post synaptic
density scaffolding proteins (D2R) in Parkinson’s disease. Results
gathered from this study revealed that D2R inhibition with the use of
haloperidol on post-natal day 20 rats (P.20) revealed a decline in the
memory index using Y-Maze [10]. But statistical analysis of the graph
plotted revealed no statistical significance difference when comparing
the haloperidol treated pups (P.20) together with the control pups with
a P value greater than 0.05 (P>0.05) using the student t-test to compare
between one variable. This means that a level of 95% confidence
interval there’s no significance difference between the means of the
control and treatment groups. Although from the graph (Figures
1a-1b) for Y maze test and NOR test [9] showed a decline in the
memory index of the neonatal animals (P.20) when compared with the
control. The results from the behavioral studies graph shows that
haloperidol inhibition reduced the memory index in NOR and also the
percentage alternation in the Y maze test. The results here infer that
blocking neurogenesis in newborns would impair learning in
newborns.
Furthermore, this study showed a decline in the PSD-95 cells (Post
synaptic density proteins) from the cell count result in Figures 2 and
3a. The PSD-95 proteins are scaffolding proteins are proteins which are
present in the membranes of dopaminergic neurons responsible for
maintaining the integrity of the neuronal membrane, they provide
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support together with the cytoskeletons such as F-actin filaments.
Results from this study showed a decline in PSD-95 (Figure 3a)
proteins and this affected the decline in memory index of the animals
(P.20) which in turn impairs learning in newborns. The decline of
PSD-95 associated with the treatment group (haloperidol treated P.20
pups) would lead to difficulty in the uptake of dopamine from neuron
to neuron, thereby inhibit neurotransmission in newborns.
Furthermore, microscopic images taken to show localization of
tyrosine hydroxylase (TH) showed increase of tyrosine hydroxylase in
the hippocampus of the treated neonates when compared to the
control (Figure 4). Looking at the graph in Figure 3b, the graph
showed a great increase in TH in the hippocampus of treated rat
newborns when compared with the control. This is expected because
in this study, the central hypothesis suggests that D2R inhibition will
increase NMDAR/AMPA dependent calcium signaling and this will in
turn increase the rate of D2R vesicle trafficking and docking on
scaffolding proteins. As a result of D2R inhibition, there would be an
over expression of D2R in the hippocampus at P.20. The result from
Figures 5a-5b is in line with the central hypothesis of this study,
increase in TH is as a result of D2R blockade which would in the end
lead to increase in the enzyme tyrosine hydroxylase (TH). The enzyme
TH is responsible for catalyzing the conversion of L-tyrosine to L-3, 4-
dihydroxyphenylalanine (Levodopa). Levodopa is a precursor of
dopamine. Because of the dopamine receptor inhibition there would
be over expression of D2R which eventually led to a decline in memory
function of haloperidol treated animals (-D2R).
Figure 2: (a) Electrophysiology results showed epoch readings with
an increase in root mean square (RMS) of the treatment group.
Statistical analysis using the student t-test showed a significant
difference (P<0.05). The increase in RMS which equates to the
increase in burst pattern of the treatment P.20 pups might be due to
D2R blockade with haloperidol which increased NMDAR/AMPA
dependent calcium signaling by opening up calcium channels,
thereby leading to increased and abnormal firing of neurons,
because influx of calcium increased the action potential of the
neurons, and in the end led to a decline in memory function of the
neonates. (b) The epoch reading here showed reduction in burst
pattern, the root mean square was reduced for the control was
haloperidol wasn’t administered.
Figure 3: (a) The graph showed a decline in the PSD-95 cells (Post
synaptic density proteins) from the cell count which was done at the
hippocampus {Cornus Ammonis (CA) and Dentate Gyrus (DG)}.
The PSD-95 proteins are scaffolding proteins are proteins which are
present in the membranes of dopaminergic neurons responsible for
maintaining the integrity of the neuronal membrane, they provide
support together with the cytoskeletons such as F-actin filaments,
newborns. The decline of PSD-95 associated with the treatment
group (haloperidol treated P.20 pups) would lead to difficulty in the
uptake of dopamine from neuron to neuron, thereby inhibit
neurotransmission in newborns. (b) Microscopic images taken to
show localization of tyrosine hydroxylase (TH) showed increase of
tyrosine hydroxylase in the hippocampus of the treated neonates
when compared to the control. The graph showed a great increase
in TH in the hippocampus of treated rat newborns when compared
with the control.
Figure 4: Microscopic image of rat P.20 neonate hippocampus
(Control and Treated) showing tyrosine hydroxylase (red) (X60).
The micrograph shows a great increase in TH in the hippocampus
of treated rat newborns when compared with the control.
More so, electrophysiology results showed epoch readings with an
increase in root mean square (RMS) of the treatment group. Statistical
analysis using the student t-test showed a significant difference
(P<0.05). The increase in RMS which equates to the increase in burst
pattern of the treatment P.20 pups might be due to D2R blockade with
haloperidol which increased NMDAR/AMPA dependent calcium
signaling by opening up calcium channels, thereby leading to increased
and abnormal firing of neurons, because influx of calcium increased
the action potential of the neurons, and in the end led to a decline in
memory function of the neonates (Figure 6).
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Figure 5: (a) The graph showed a decline in the PSD-95 cells (Post
synaptic density proteins) from the cell count which was done at the
hippocampus {Cornus Ammonis (CA) and Dentate Gyrus (DG)}.
The PSD-95 proteins are scaffolding proteins are proteins which are
present in the membranes of dopaminergic neurons responsible for
maintaining the integrity of the neuronal membrane, they provide
support together with the cytoskeletons such as F-actin filaments.
Newborns: The decline of PSD-95 associated with the treatment
group (haloperidol treated P.20 pups) would lead to difficulty in the
uptake of dopamine from neuron to neuron, thereby inhibit
neurotransmission in newborns. (b) Microscopic images taken to
show localization of tyrosine hydroxylase (TH) showed increase of
tyrosine hydroxylase in the hippocampus of the treated neonates
when compared to the control. The graph showed a great increase
in TH in the hippocampus of treated rat newborns when compared
with the control.
Figure 6: (a) Electrophysiology results showed epoch readings with
an increase in root mean square (RMS) of the treatment group.
Statistical analysis using the student t-test showed a significant
difference (P<0.05). The increase in RMS which equates to the
increase in burst pattern of the treatment P.20 pups might be due to
D2R blockade with haloperidol which increased NMDAR/AMPA
dependent calcium signaling by opening up calcium channels,
thereby leading to increased and abnormal firing of neurons,
because influx of calcium increased the action potential of the
neurons, and in the end led to a decline in memory function of the
neonates (b) The epoch reading here showed reduction in burst
pattern, the root mean square was reduced for the control were
haloperidol wasn’t administered.
Conclusion
Inhibition of dopamine receptor D2R AND Post Synaptic Density
Protein D2R showed a decline in memory function in cognition in
neonates and it was associated with irregular burst pattern s via
electrophysiology and decline in memory index via NOR and Y-maze
behavioral study test. This study revealed via electrophysiology,
immunolocalization and behavioral studies that D2R decline in
memory function in neonates, and may equally lead to memory
impairment which may concurrently lead to progressive Parkinsonism
and Schizophrenia.
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